Wet granulation remains a critical unit operation in solid oral dosage manufacturing, particularly for formulations with poor flowability, low compressibility, or challenging API characteristics (very high or low dose and compressibility). As regulatory expectations and manufacturing technologies continue to evolve, manufacturers must focus on formulation and process understanding, control, and reproducibility.
Below are key technical considerations and current best practices shaping wet granulation today.
Process Understanding as the Foundation
Modern wet granulation development is firmly aligned with Quality by Design (QbD) principles. A thorough understanding of:
- Critical Material Attributes (CMAs)
- Critical Process Parameters (CPPs)
- Critical Quality Attributes (CQAs)
Is essential to build a robust, scalable process.
Parameters such as binder type, liquid-to-solid ratio, impeller speed, granulation time, and drying conditions must be scientifically justified and clearly linked to tablet performance.
Binder Selection and Addition Strategy
Rational binder selection is essential to achieve optimal granule strength, repeatable size distribution, and robust tablet compressibility. Key selection parameters include:
- Optimal binder solution surface tension / substrate wettability
- Optimization of binder viscosity and concentration
- Evaluation of spray rate and droplet size during addition
- Selection between solution vs. suspension-based binders
Controlled and reproducible binder delivery is critical to avoid over-granulation or friable granules.
Advanced Process Monitoring and Control
The integration of Process Analytical Technology (PAT) tools is increasingly common in wet granulation operations, Inline and at-line measurements such as:
- Moisture content (NIR)
- Granule growth kinetics
- Torque and power consumption
- Temperature profiles
These enable real-time process understanding and support consistent batch quality and reduced process variability.
Drying: A Critical but Often Undervalued Step
Drying directly impacts granule stability, flow, and tablet performance. Current best practices include:
- Defined moisture endpoints rather than fixed drying times
- API-specific thermal exposure limits
- Uniform airflow and load control in fluid bed dryers
Over drying can negatively affect compressibility, while insufficient drying increases sticking and stability risks.
Data-Driven Optimization and Digitalization
Manufacturers are increasingly leveraging:
- Historical batch data
- Predictive models
- Advanced analytics and AI tools
To improve process robustness, reduce scale-up risk, and optimize cycle times. Data-driven decision making is becoming an integral part of wet granulation lifecycle management.
Operator Expertise and Process Discipline
Despite technological advances, wet granulation remains highly dependent on operator skill and procedural discipline. Clear SOPs, standardized operating ranges, and continuous training remain essential for maintaining process consistency.
Conclusion
Wet granulation continues to evolve from an experience-based operation to a scientifically controlled, data-enabled process. Manufacturers that invest in process understanding, real-time monitoring, and cross-functional collaboration will achieve greater robustness, regulatory confidence, and operational efficiency.
Enablers Excipients for wet granulation including:
- Binders: Cellulose derivatives such as: Hydroxypropyl cellulose (HPC). Hypromellose (HPMC), Methyl Cellulose (MC), Sodium Carboxymethyl cellulose (NaCMC). Vinyl Pyrrolidone Derivatives: Povidone (PVP), Copovidone (PVP-PVA). Starches & Sugars: Native Starch, Pregelatinized and partially pregelatinized Starch, Sucrose, Glucose, etc.
- Filler/Binders: Lactose; Microcrystalline Cellulose (MCC); Dicalcium Phosphate; Mannitol; Partially pregelatinized Starch.
- Disintegrants: Sodium Starch Glycolate (SSG); Croscarmellose Sodium; Crospovidone; Low substituted HPC (L-HPC).
- Solvents and wetting agents: Water; Ethanol; Isopropanol; Polysorbate; Polymers like HPC are also good wetting agents.
For additional details about any of these ingredients or to discover how Barentz can assist with your formulation needs, please contact us at:
North and Central America: info-pharmaus@barentz.com
South America: suporte.br@barentz.com
Europe Middle East & Africa: pharma@barentz.com